Task: Answer the multiple-choice question.
Question: Which drug exhibits a -61.044% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CCN(CC)S(=O)(=O)c1ccc(O)c(NC(=O)c2cc(-c3cc(OC)c(OC)c(OC)c3)nc3ccccc23)c1
b.) Cc1ccc(-c2ccc(=O)n(CCC(=O)NCc3ccccn3)n2)cc1
Answer: b. Cc1ccc(-c2ccc(=O)n(CCC(=O)NCc3ccccn3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2ccc(=O)n(CCC(=O)NCc3ccccn3)n2)cc1
Cc1ccc(-c2ccc(=O)n(CCC(=O)NCc3ccccn3)n2)cc1
3-[3-(4-methylphenyl)-6-oxopyridazin-1-yl]-N-(pyridin-2-ylmethyl)propanamide